390 related articles for article (PubMed ID: 26413814)
1. Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells.
Thotala D; Karvas RM; Engelbach JA; Garbow JR; Hallahan AN; DeWees TA; Laszlo A; Hallahan DE
Oncotarget; 2015 Oct; 6(33):35004-22. PubMed ID: 26413814
[TBL] [Abstract][Full Text] [Related]
2. Cellular Effects of the Antiepileptic Drug Valproic Acid in Glioblastoma.
Eckert M; Klumpp L; Huber SM
Cell Physiol Biochem; 2017; 44(4):1591-1605. PubMed ID: 29212069
[TBL] [Abstract][Full Text] [Related]
3. Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation.
Yazlovitskaya EM; Edwards E; Thotala D; Fu A; Osusky KL; Whetsell WO; Boone B; Shinohara ET; Hallahan DE
Cancer Res; 2006 Dec; 66(23):11179-86. PubMed ID: 17145862
[TBL] [Abstract][Full Text] [Related]
4. Sodium valproate prevents radiation-induced injury in hippocampal neurons via activation of the Nrf2/HO-1 pathway.
Liao G; Li R; Chen X; Zhang W; Du S; Yuan Y
Neuroscience; 2016 Sep; 331():40-51. PubMed ID: 27328419
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid attenuates neuronal loss in the brain of APP/PS1 double transgenic Alzheimer's disease mice model.
Long Z; Zheng M; Zhao L; Xie P; Song C; Chu Y; Song W; He G
Curr Alzheimer Res; 2013 Mar; 10(3):261-9. PubMed ID: 23036022
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinoma.
Shoji M; Ninomiya I; Makino I; Kinoshita J; Nakamura K; Oyama K; Nakagawara H; Fujita H; Tajima H; Takamura H; Kitagawa H; Fushida S; Harada S; Fujimura T; Ohta T
Int J Oncol; 2012 Jun; 40(6):2140-6. PubMed ID: 22469995
[TBL] [Abstract][Full Text] [Related]
7. HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cells.
Chen X; Wong P; Radany E; Wong JY
Cancer Biother Radiopharm; 2009 Dec; 24(6):689-99. PubMed ID: 20025549
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of valproic acid following transient global ischemia in rats.
Xuan A; Long D; Li J; Ji W; Hong L; Zhang M; Zhang W
Life Sci; 2012 Mar; 90(11-12):463-8. PubMed ID: 22285595
[TBL] [Abstract][Full Text] [Related]
9. Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation.
Yu JI; Choi C; Shin SW; Son A; Lee GH; Kim SY; Park HC
Sci Rep; 2017 Nov; 7(1):14986. PubMed ID: 29118323
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid induces apoptosis in differentiating hippocampal neurons by the release of tumor necrosis factor-α from activated astrocytes.
Wang C; Luan Z; Yang Y; Wang Z; Cui Y; Gu G
Neurosci Lett; 2011 Jun; 497(2):122-7. PubMed ID: 21543053
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation.
Mawatari T; Ninomiya I; Inokuchi M; Harada S; Hayashi H; Oyama K; Makino I; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2015 Dec; 47(6):2073-81. PubMed ID: 26497673
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of valproic acid in DNA double-strand break repair after irradiation in esophageal squamous carcinoma cells.
Makita N; Ninomiya I; Tsukada T; Okamoto K; Harada S; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Oncol Rep; 2015 Sep; 34(3):1185-92. PubMed ID: 26135807
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.
Sun L; Qian Q; Sun G; Mackey LV; Fuselier JA; Coy DH; Yu CY
J Drug Target; 2016; 24(2):169-77. PubMed ID: 26211366
[TBL] [Abstract][Full Text] [Related]
15. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation.
Tsolmongyn B; Koide N; Odkhuu E; Haque A; Naiki Y; Komatsu T; Yoshida T; Yokochi T
Cell Immunol; 2013 Apr; 282(2):100-5. PubMed ID: 23770718
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modifiers as anticancer drugs: effectiveness of valproic acid in neural crest-derived tumor cells.
Papi A; Ferreri AM; Rocchi P; Guerra F; Orlandi M
Anticancer Res; 2010 Feb; 30(2):535-40. PubMed ID: 20332466
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A
J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.
Thotala DK; Hallahan DE; Yazlovitskaya EM
Cancer Res; 2008 Jul; 68(14):5859-68. PubMed ID: 18632640
[TBL] [Abstract][Full Text] [Related]
20. Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition.
Li Y; Yuan Z; Liu B; Sailhamer EA; Shults C; Velmahos GC; Demoya M; Alam HB
J Trauma; 2008 Apr; 64(4):863-70; discussion 870-1. PubMed ID: 18404049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
